Wall Street Zen Downgrades SBC Medical Group (NASDAQ:SBC) to Buy

Key Points

• SBC Medical Group's stock rating has been lowered from a "strong-buy" to a "buy" by Wall Street Zen, reflecting a shift in analysts' confidence.
• Despite a 9.9% increase in stock price recently, the company reported disappointing earnings, missing the consensus estimate by $0.12 per share.
• Institutional investors hold 60.82% of SBC Medical Group's shares, with several large investors significantly increasing their stakes during the second quarter.

SBC Medical Group (NASDAQ:SBC - Get Free Report) was downgraded by equities research analysts at Wall Street Zen from a "strong-buy" rating to a "buy" rating in a report issued on Saturday.

SBC Medical Group Trading Down 2.4%

Shares of NASDAQ:SBC traded down $0.10 on Friday, reaching $3.99. 33,804 shares of the company traded hands, compared to its average volume of 47,032. The business's 50-day simple moving average is $4.60 and its 200 day simple moving average is $4.21. SBC Medical Group has a 52 week low of $2.62 and a 52 week high of $19.50. The stock has a market capitalization of $413.40 million, a P/E ratio of 12.47 and a beta of 1.27. The company has a current ratio of 3.98, a quick ratio of 3.95 and a debt-to-equity ratio of 0.03.

SBC Medical Group (NASDAQ:SBC - Get Free Report) last announced its quarterly earnings data on Wednesday, August 13th. The company reported $0.02 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.14 by ($0.12). The company had revenue of $43.36 million for the quarter, compared to the consensus estimate of $44.71 million. SBC Medical Group had a net margin of 17.71% and a return on equity of 20.76%. As a group, equities analysts anticipate that SBC Medical Group will post 5.02 EPS for the current fiscal year.

Institutional Trading of SBC Medical Group

Several large investors have recently modified their holdings of SBC. SBI Securities Co. Ltd. grew its stake in shares of SBC Medical Group by 227.3% in the second quarter. SBI Securities Co. Ltd. now owns 54,177 shares of the company's stock worth $251,000 after purchasing an additional 37,623 shares during the last quarter. Geode Capital Management LLC bought a new stake in shares of SBC Medical Group in the second quarter worth about $455,000. XTX Topco Ltd bought a new stake in shares of SBC Medical Group in the second quarter worth about $64,000. Finally, New York State Common Retirement Fund bought a new stake in shares of SBC Medical Group in the second quarter worth about $104,000. 60.82% of the stock is owned by institutional investors.

About SBC Medical Group

SBC Medical Group Holdings Incorporated, through its subsidiaries, provides services to support the operation of clinics which deliver specialized medical services in the areas of cosmetic medicine, esthetic dentistry and Androgenetic Alopecia or AGA, primarily in Japan and centered on the SBC Shonan Beauty Clinic Brand.